Epiregulin (EREG) and Myocardin Related Transcription Factor A (MRTF-A) Form a Feedforward Loop to Drive Hepatic Stellate Cell Activation
Xiaoyan Wu(Shenzhen University), Yong Xu(Liaocheng University), Longcheng Shang(China Pharmaceutical University), Haozhen Ren(Nanjing Drum Tower Hospital), Tianyi Zhang(Nanjing Medical University), Zhengyi Zhu(Nanjing Drum Tower Hospital), Wei Zhu(Ministry of Education of the People's Republic of China), Xiaolei Shi(Nanjing Drum Tower Hospital), Jinglin Wang(Guizhou Provincial People's Hospital), Wenhui Dong(Weifang People's Hospital)
Cited by 29
Related Papers
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
|Annals of the Rheumatic Diseases|2011|412
Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases
|PLoS ONE|2012|196
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
|Annals of the Rheumatic Diseases|2013|168